Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials to the Overall Type 2 Diabetes Population in the United States

Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.13649
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management

South African Family Practice
2013English

The Association of the Treatment With Glucagon-Like Peptide-1 Receptor Agonist Exenatide or Insulin With Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Retrospective Observational Study

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2015English

Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Clinical Drug Investigation
MedicinePharmacology
2020English

Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2015English

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

The Key Role of a Glucagon-Like Peptide-1 Receptor Agonist in Body Fat Redistribution

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy